BD Announces Strong Fiscal 2024 Results: A Look at Fourth Quarter and Full Year Financial Performance

Strong Growth and Margin Execution Drives Performance in Quarter Becton, Dickinson and Company (BD) Reports Impressive Q4 Results FRANKLIN LAKES, N.J. , Nov. 7, 2024 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fiscal 2024 fourth quarter and full year which ended September…

Read More

AIM ImmunoTech Halts Plans for Form S-1 Offering Until After Filing Annual Report on Form 10-K

AIM ImmunoTech Delays Securities Offering OCALA, Fla., Feb. 11, 2025 – AIM ImmunoTech Inc. (AIM), a clinical-stage biotech company specializing in the discovery and development of therapeutic compounds to treat various diseases, announced that it will postpone its planned securities offering under Registration Statement on Form S-1. This decision was made due to the Company’s…

Read More

Powering Up: New Zealand Energy Corp. Reveals Impressive Q2 2024 Results!

New Zealand Energy Corp Announces Q2 2024 Financial Results Wellington, New Zealand–(Newsfile Corp. – August 28, 2024) New Zealand Energy Corp. (TSXV: NZ) (“NZEC” or the “Company”) announced today that it has filed with Canadian regulatory authorities its Q2 2024 consolidated financial results and an accompanying management discussion and analysis report. The documents are now…

Read More

“Uncovering the Truth: Ongoing Investigation of Olin Corporation – Contact Levi and Korsinsky for Updates!”

Investigation Commenced on Olin Corporation February 15, 2025 | New York, NY Levi & Korsinsky, a leading law firm, has officially launched an investigation into Olin Corporation (NYSE:OLN) for potential violations of federal securities laws. This investigation comes in response to a press release issued by Olin Corporation on January 30, 2025, announcing its financial…

Read More